March 31, 2026

Recursion Pharmaceuticals, Inc. (RXRX) Investor Outlook: Is a 136% Upside within Reach?

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company, is making waves with its innovative approach to drug discovery. With a market capitalization of $1.5 billion, this Salt Lake City-based..

PACS Group, Inc. (PACS) Stock Analysis: A 52.73% Potential Upside in Healthcare Facilities

PACS Group, Inc. (NASDAQ: PACS) is drawing significant investor attention with a remarkable potential upside of 52.73%, according to analyst ratings. As a key player in the healthcare sector, PACS..

Astrana Health Inc. (ASTH) Stock Analysis: Explore a Potential Upside of 47.90%

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is garnering investor attention with its robust revenue growth and compelling analyst ratings. As a healthcare management company, Astrana..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a 44.91% Potential Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology industry, is drawing attention from investors with a compelling potential upside of 44.91%. This biopharmaceutical company, headquartered in Burlingame, California,..

NeoGenomics, Inc. (NEO) Stock Analysis: Unlocking Potential with a 105.73% Upside

NeoGenomics, Inc. (NASDAQ: NEO) presents a compelling opportunity for investors seeking exposure to the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $934.65 million,..

Aurinia Pharmaceuticals Inc (AUPH) Investor Outlook: Exploring a 21.60% Upside Potential

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is generating interest in the investment community with an enticing potential upside of 21.60%. This Canadian biotechnology firm, specializing in treatments for autoimmune diseases, has..

Kymera Therapeutics (KYMR) Stock Analysis: Exploring a 49.90% Potential Upside in Biotechnology

Kymera Therapeutics, Inc. (NASDAQ: KYMR) stands out in the biotechnology sector with its innovative approach to drug development and a striking potential upside of nearly 50%, as indicated by its..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Is There Growth Potential in Healthcare?

Pediatrix Medical Group, Inc. (NYSE: MD) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.73 billion, this..

Phreesia, Inc. (PHR) Stock Analysis: A Healthcare SaaS Company with a Potential Upside of 142.17%

Phreesia, Inc. (PHR) has emerged as a notable player in the healthcare sector, specializing in Health Information Services. Based in Wilmington, Delaware, Phreesia offers an integrated SaaS-based software and payment..

BioLife Solutions, Inc. (BLFS): Investor Outlook with 72% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing the attention of investors with its robust growth..

Haemonetics Corporation (HAE): Investor Outlook on Potential Upside and Analyst Ratings

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, stands out in the medical devices industry with a market capitalization of $2.57 billion. The Boston-based company specializes in..

Adaptive Biotechnologies (ADPT) Stock Analysis: Unveiling a 62% Potential Upside

For investors seeking promising opportunities within the healthcare sector, Adaptive Biotechnologies Corporation (NASDAQ: ADPT) presents an intriguing case. With a market capitalization of $1.98 billion, this U.S.-based biotechnology company is..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Promising 50.88% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is currently attracting attention from individual investors thanks to its potential 50.88% upside, as indicated by recent analyst ratings. This biopharmaceutical company, headquartered in Rancho..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Uncovering a 53.65% Potential Upside in the Biotech Arena

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands as a compelling player in the biotechnology sector, focusing on niche markets like rare kidney and metabolic diseases. With its headquarters in San Diego,..

Teladoc Health, Inc. (TDOC) Investor Outlook: Unlocking a 37% Potential Upside Amidst Market Challenges

Teladoc Health, Inc. (NYSE: TDOC) remains a compelling consideration in the ever-evolving healthcare sector, particularly within the health information services industry. As a pioneer in virtual healthcare services, Teladoc continues..

Concentra Group Holdings (CON): A 37.77% Upside Potential with Robust Analyst Confidence

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a formidable player in the healthcare sector, specifically within the medical care facilities industry, is capturing the attention of investors with its compelling..

Harrow, Inc. (HROW) Stock Analysis: Unveiling a 108% Potential Upside in the Ophthalmic Pharmaceutical Sector

Harrow, Inc. (NASDAQ: HROW) is capturing investor attention with a compelling narrative in the healthcare sector, particularly within the niche of ophthalmic pharmaceuticals. With a market capitalization of $1.24 billion,..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A 34.67% Upside Amidst Robust Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector, piquing investor interest with its promising pipeline and potential for significant upside. With a market capitalization of $1.73..

GRAIL, Inc. (GRAL) Investor Outlook: Exploring a 54% Potential Upside in the Healthcare Diagnostics Sector

GRAIL, Inc. (NASDAQ: GRAL), a pioneering player in the healthcare diagnostics sector, is drawing significant attention from investors due to its promising potential upside of 54.37%. As a commercial-stage company..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 127% Potential Upside Amidst Market Challenges

QuidelOrtho Corporation (NASDAQ: QDEL) is a prominent player in the healthcare sector, specifically within the medical devices industry. Based in San Diego, California, the company specializes in providing cutting-edge diagnostic..

Search

Funds

March 31, 2026

Search

Funds

March 31, 2026

FTSE 100

Funds